As used in this chapter:
(1) "Brand name" means the proprietary or trade name placed upon a drug, its container, label or wrapping at the time of packaging;
(2) "Generic name" means the United States Adopted Name (USAN) or the official title of a drug published in the latest edition of a nationally recognized pharmacopoeia or formulary;
(3) "Substitute" means to dispense, with the practitioner's authorization, a "therapeutically equivalent" generic drug product of identical drug salt or an interchangeable biological product in place of the drug or biological product ordered or prescribed;
(4) "Therapeutically equivalent" means the same efficacy and toxicity when administered to an individual in the same dosage form; and
(5) "Practitioner" means a physician, osteopath, dentist, podiatrist, veterinarian, or any other person authorized to prescribe drugs under the laws of this State.
HISTORY: 1978 Act No. 595 Section 2; 2017 Act No. 11 (H.3438), Section 1, eff April 24, 2017.
Effect of Amendment
2017 Act No. 11, Section 1, in (3), inserted "or an interchangeable biological product" and "or biological product".
Structure South Carolina Code of Laws
Chapter 24 - Drug Product Selection Act
Section 39-24-10. Short title.
Section 39-24-20. Definitions.
Section 39-24-40. Prescription shall state whether substitution is permitted; consent of patient.
Section 39-24-50. Retroactive effect.
Section 39-24-60. Out-of-state and United States Government prescriptions.